On the contrary, Helgadottir et al., comparing the survival in germline CDKN2A mutated and nonmutated melanoma cases, found the CDKN2A mutated cases had statistically significantly worse survival than melanoma cases with no CDKN2A mutations [130]. The gene discussed is CDKN2A; the disease is melanoma.